ImmunityBio, Inc. IBRX Finite-Lived Intangible Assets, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s finite-lived intangible assets, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s finite-lived intangible assets, accumulated amortization?
- ImmunityBio, Inc. (IBRX) reported finite-lived intangible assets, accumulated amortization of $9.03M in Q1 2026.
- How has ImmunityBio, Inc.'s finite-lived intangible assets, accumulated amortization changed year-over-year?
- ImmunityBio, Inc.'s finite-lived intangible assets, accumulated amortization increased by 41.6% year-over-year, from $6.38M to $9.03M.
- What is the long-term trend for ImmunityBio, Inc.'s finite-lived intangible assets, accumulated amortization?
- Over 3 years (2022 to 2025), ImmunityBio, Inc.'s finite-lived intangible assets, accumulated amortization has grown at a 60.2% compound annual growth rate (CAGR), from $1.94M to $7.96M.